Log in or Sign up for Free to view tailored content for your specialty!
Hormone Therapy News
17-beta estradiol involved in down-regulation of TRAIL, CV health
Blood concentrations of tumor necrosis factor-related apoptosis-inducing ligand, or TRAIL, appear to be inversely related to levels of 17-beta estradiol, according to recent study data.
BMD results after GH therapy not better in hypopituitary patients
In patients with hypopituitarism, a 2-year regimen of growth hormone therapy does not confer greater benefits in bone mineral density upon those receiving glucocorticoid therapy, according to recent study findings.
Log in or Sign up for Free to view tailored content for your specialty!
Testosterone therapy increased risk for acute MI in some men
The risk for acute MI within 90 days of testosterone therapy prescription is elevated in older men and younger men with a prior history of CVD, according to new study data.
FDA to evaluate risk for CV events with testosterone therapy
The FDA announced today that it is reassessing the risk for stroke, MI and death in men who use FDA-approved testosterone products, according to a safety announcement.
Postmenopausal HT could lessen risk for primary open-angle glaucoma
Postmenopausal hormone therapy containing estrogen could reduce the risk for primary open-angle glaucoma, retrospective data suggest.
Radiotherapy plus hormone therapy halved prostate cancer mortality
The addition of radiation therapy to antiandrogen therapy halved the 10- and 15-year rates for mortality among men with high-risk nonmetastatic prostate cancer compared with hormone therapy alone, according to updated study results presented at the 2014 Genitourinary Cancers Symposium.
Bazedoxifene/conjugated estrogens yielded low endometrial hyperplasia rates, improved BMD
Combination bazedoxifene and conjugated estrogens demonstrated low rates of endometrial hyperplasia, with improved lumbar spine and total hip bone mineral density in postmenopausal women, according to initial data published in the Journal of Clinical Endocrinology and Metabolism.
Increased risk for acute pancreatitis found with HT
The use of postmenopausal hormone therapy may increase the risk for acute pancreatitis, according to research published in the Canadian Medical Association Journal.
HT lessened risk for repeat knee, hip replacement surgery
Hormone therapy was associated with approximately 40% reductions in repeat surgeries after a total knee arthroplasty or total hip arthroplasty, according to data derived from a population-based retrospective cohort study.
GH/testosterone not superior to testosterone alone in bone of hypopituitary men
Combined treatment with growth hormone and testosterone in men with hypopituitarism does not appear to yield improvements in structural or mechanical measures of the distal tibia vs. testosterone alone, according to recent study results.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read